No Prescription |
 |
 | ||
|
VERADANAFIL Levitra |
|
| ||
No Prescription » Prescription Drugs 17 » VERADANAFIL Levitra Vardenafil is used to treat male sexual function problems (impotence or erectile dysfunction) by blocking a certain enzyme (phosphodiesterase-PDE5). In combination with sexual stimulation vardenafil works by helping the blood flow into the penis to achieve and maintain an erection.This drug is not indicated for use in women.Use of this drug does not protect against sexually transmitted diseases (e.g. HIV hepatitis B gonorrhea syphilis). Practice "safe sex" such as using latex condoms. Consult your doctor or pharmacist for more details.How to use Vardenafil OralThis drug is taken by mouth as needed 1 hour before sexual activity with or without food; or use as directed by your doctor. Do not take more often than once daily as needed.A high fat meal may decrease the amount of drug that is absorbed.Avoid eating grapefruit or drinking grapefruit juice while you are being treated with this medication unless your doctor instructs you otherwise.The dosage is based on your medical condition response to therapy and other medications you may be taking (see also Drug Interactions section). Consult your doctor or pharmacist for more details.Read the patient information leaflet provided by your pharmacist and ask questions if any of the information is unclear. Buy VERADANAFIL Levitra and other Prescription Drugs 17 products online at Medstore. 1000
About VERADANAFIL Levitra: Product Type: Prescription Drugs 17 VERADANAFIL ( Levitra Generic Veradanfil ) VERADANAFIL (Levitra Generic Veradanfil) Levitra Generic Veradanfil 20mg Tabs 10 Levitra Generic Veradanfil VERADANAFIL
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
